D. Sevin

Phase II trial of methotrexate-FAM (m-FAM) in adenocarcinoma of unknown primary.

P. Woolley, T. le Chevalier, C. Tremblay, 1989, European journal of cancer & clinical oncology.

Single-agent estramustine phosphate (EMP) is active in advanced breast cancer after failure with anthracyclines and taxanes.

L. Zelek, M. Spielmann, K. Fizazi, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomised trial of maintenance therapy for non metastatic inflammatory breast cancer (IBC)

T. Delozier, P. Kerbrat, C. Noguès, 1993 .

A phase I trial with recombinant interferon γ (Roussel UCLAF) in advanced cancer patients

T. Tursz, T. Chevalier, M. Spielmann, 2005, Cancer Immunology, Immunotherapy.

Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas

T. le Chevalier, M. Spielmann, G. Contesso, 1987, Cancer.